Patent Assignment
Reel/Frame 029942/0562
Confirmatory License
Recorded: 2013-03-08
Pages: 2
Assignor
SUREGENE, LLC
Executed: 2013-02-18
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Methods and Compositions for the Treatment of Psychotic Disorders Through the Identification of the Olanzapine Poor Response Predictor Genetic Signature
Patent:
7,932,042 →
Application:
12/903,891 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 13, 2010
From: RAMSEY, TIMOTHY L.; MEHROTRA, BHARAT; BRENNAN, MARK D.
To: SUREGENE, LLC
Reel/Frame 025134/0121 →
Confirmatory License
Feb 19, 2013
From: SUREGENE, LLC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029827/0313 →
Assignment of Assignor's Interest
May 2, 2016
From: SUREGENE, LLC
To: CLINICAL REFERENCE LABORATORY, INC.
Reel/Frame 038432/0590 →